carboxyamido-triazole has been researched along with Disease Models, Animal in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Afzal, A; Caballero, S; Edelhauser, H; Franklin, A; Geroski, D; Grant, MB; Hochhaus, G; Jurczyk, S; Kim, M; Palii, SS; Pardue, M; Shapiro, G | 1 |
Franklin, AJ; Jetton, TL; Kohn, EC; Kuchemann, CL; Russell, SR | 1 |
Borel, CO; Laskowitz, DT; Lombard, FW; Mesis, RG; Vitek, MP; Wang, H; Warner, DS; Yates, R | 1 |
Chen, W; Guo, L; Li, J; Yang, H; Ye, C; Ye, H; Yu, X; Zhang, D; Zheng, R | 1 |
5 other study(ies) available for carboxyamido-triazole and Disease Models, Animal
Article | Year |
---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Targeting retinal and choroid neovascularization using the small molecule inhibitor carboxyamidotriazole.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents; beta-Cyclodextrins; Bromodeoxyuridine; Cell Proliferation; Cells, Cultured; Choroidal Neovascularization; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Electroretinography; Epithelial Cells; Female; Humans; Injections, Intraocular; Laminin; Mice; Proteoglycans; Rabbits; Rats; Retina; Retinal Neovascularization; Retinal Vessels; Triazoles | 2010 |
CAI is a potent inhibitor of neovascularization and imparts neuroprotection in a mouse model of ischemic retinopathy.
Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Antineoplastic Agents; Disease Models, Animal; Fluorescein Angiography; Hyperoxia; In Situ Nick-End Labeling; Ischemia; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Neuroprotective Agents; Proto-Oncogene Proteins c-bcl-2; Retinal Neovascularization; Retinal Vessels; Triazoles | 2004 |
Dissociation between vasospasm and functional improvement in a murine model of subarachnoid hemorrhage.
Topics: Animals; Antihypertensive Agents; Apolipoproteins E; Behavior, Animal; Calcium Channel Blockers; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred C57BL; Middle Cerebral Artery; Neurologic Examination; Nimodipine; Peptides; Reaction Time; Rotarod Performance Test; Subarachnoid Hemorrhage; Treatment Outcome; Triazoles; Vasospasm, Intracranial | 2006 |
Anti-inflammatory and analgesic potency of carboxyamidotriazole, a tumorostatic agent.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Arthritis; Capillary Permeability; Disease Models, Animal; Edema; Female; Granuloma; Interleukin-1; Male; Mice; Mice, Inbred ICR; Pain; Pain Measurement; Rats; Rats, Wistar; Triazoles; Tumor Necrosis Factor-alpha | 2008 |